Resources
About Us
Home Report
Store
Human Milk Oligosaccharides (HMOs) Market
Human Milk Oligosaccharides (HMOs) Market Size, Share, Forecast, & Trends Analysis by Type (2'FL, 3'FL, 3'SL, 6'SL, LNT, LNnT), Concentration (Neutral, Acidic), Application (Infant Formula, Dietary Supplements, Food & Beverages)—Global Forecast to 2031
Report ID:MRFB - 1041382 Pages: 220 Oct-2024 Formats*: PDF Category: Food and Beverages Delivery: 24 to 72 HoursThe Human Milk Oligosaccharides (HMOs) market was valued at $0.35 billion in 2023. This market is expected to reach $1.71 billion by 2031 from an estimated $0.45 billion in 2024, at a CAGR of 21.2% during the forecast period from 2024 to 2031.
Human Milk Oligosaccharides (HMOs) Market Size & Forecast
The growth of this market is driven by the rising demand for infant nutrition and dietary supplements, increasing awareness regarding the benefits of HMOs, and increased product innovation by various human milk oligosaccharides (HMOs) manufacturers. Moreover, increasing technological advancements and government approvals for the use of HMOs for human consumption are expected to generate growth opportunities.
Key Findings Human Milk Oligosaccharides (HMOs) Market
- By Type: In 2024, the 2’FL Segment to Dominate the Human Milk Oligosaccharides (HMOs) Market
- By Concentration: In 2024, the Neutral Segment is Expected to Dominate the Human Milk Oligosaccharides (HMOs) Market
- By Application: In 2024, the Infant Formula Segment is Expected to Dominate the Human Milk Oligosaccharides (HMOs) Market
- By Geography: North America to Dominate the Human Milk Oligosaccharides (HMOs) Market in 2024
-Market.webp "Human Milk Oligosaccharides (HMOs) Market")
Click here to: Get Free Sample Copy of this report
Human Milk Oligosaccharides (HMOs) Market Drivers
Rising Demand for Infant Nutrition
The demand for infant nutrition is increasing, driven by its associated benefits and the growing availability of diverse products in the market. With the global population projected to rise by nearly 2 billion, from 8 billion in 2022 to 9.7 billion by 2050, the expanding infant population is expected to further boost the demand for infant nutrition.
However, the increase in dual-income households, coupled with a growing population of working mothers, has heightened the reliance on convenient, ready-to-use infant nutrition products. Additionally, there is a rising awareness among parents regarding their children’s nutritional needs for cognitive and physical development. As a result, many parents are choosing products that meet these nutritional requirements, often opting for organic and allergen-free options. These trends are significantly driving the growth of the HMO market.
Increasing Awareness Regarding the Benefits of HMO
In recent years, the demand for infant nutrition has surged significantly, with HMOs gaining traction due to their various health benefits for infants. Parents are increasingly aware of the importance of incorporating HMOs into their baby's daily nutrition. Furthermore, due to their substantial health advantages, many consumers are opting for dietary supplements that contain HMOs.
HMOs play a crucial role in infants' health by enhancing immune function through the promotion of beneficial gut bacteria and acting as decoys for pathogens, thereby lowering the risk of infections. Additionally, HMOs contribute to cognitive development by supporting brain growth during early life stages. They also improve gastrointestinal health by fostering beneficial bacteria in the gut microbiome, which is essential for overall health and well-being. These factors have led to increased utilization of HMOs in various supplements, and the growing awareness of their benefits is further supporting market growth.
Human Milk Oligosaccharides (HMOs) Market Opportunities
Increasing Technological Advancements
The HMO market is experiencing significant technological advancements that enhance the efficiency, scalability, and diversity of HMO synthesis. Advances in enzyme engineering have enabled more controlled and efficient synthesis through transglycosylation techniques. Additionally, chemoenzymatic synthesis combines chemical methods with enzymatic reactions, providing greater flexibility and efficiency in HMO production. Furthermore, innovative research is exploring the use of transgenic plants as platforms for HMO production, allowing for the engineering of plants to produce complex HMOs at a lower cost compared to microbial systems. As a result, these technological advancements are expected to present substantial growth opportunities for players in the Human Milk Oligosaccharides (HMOs) market in the coming years.
Human Milk Oligosaccharides (HMOs) Market Analysis: Top Market Opportunity:
The 2’FL Segment is Expected to Dominate the Human Milk Oligosaccharides (HMOs) Market in 2024
Based on type, the human milk oligosaccharides (HMOs) market is segmented into 2’FL, 3’FL, 3’SL, 6’SL, LNT, LNnT, and DFL. In 2024, the 2’FL segment is expected to account for the largest share of the human milk oligosaccharides (HMOs) market. The substantial market share of this segment is primarily driven by its high product availability since its approval in 2016, a growing preference for HMOs due to their numerous health benefits and diverse applications, an increasing demand for infant formulas containing HMOs, and the rising incorporation of 2'FL into these infant formula products.
Geographical Analysis
North America Dominates the Human Milk Oligosaccharides (HMOs) Market in 2024
In 2024, North America is estimated to account for the largest share of the global Human Milk Oligosaccharides (HMOs) market. North America’s significant share of the human milk oligosaccharides (HMOs) market can be primarily attributed to heightened awareness of the health benefits of HMOs, increasing consumer preference for HMO-based products, a growing trend toward personalized nutrition with a focus on gut health, technological advancements in the region, and strong government support for regulatory frameworks and policies.
However, the Asia-Pacific region is slated to register the highest CAGR during the forecast period. This growth is driven by increasing preferences for infant nutrition, a rising infant population in the region, higher spending on health-related products, and expanding product offerings from key market players.
Key Companies
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years (2021-2024).
The key players profiled in the global human milk oligosaccharides (HMOs) market report are Chr. Hansen A/S (A part of Novonesis) (Denmark), DSM-Firmenich AG (Switzerland), Kyowa Hakko Europe GmbH (Germany), Royal FrieslandCampina N.V. (Netherlands), ZuChem Inc. (U.S.), ELICITYL S.A. (France), Dextra Laboratories Limited (U.K.), Glycosyn LLC (U.S.), Nestle Health Science (U.S.), Biosynth Ltd (U.K.), Inbiose NV (Belgium), BASF SE (Germany), and Abbott Laboratories (U.S.), among others.
Human Milk Oligosaccharides (HMOs) Industry Overview: Latest Developments from Key Industry Players
-
In January 2024, Royal FrieslandCampina N.V. (Netherlands) got approval for its 2’-Fucosyllactose (2’-FL) ingredient, Aequival, in Thailand to use in infant formula.
-
In January 2024, DSM-Firmenich AG (Switzerland) received approval for four more human milk oligosaccharide (HMO) ingredients by Food Standards Australia New Zealand (FSANZ) to use in infant formula.
- In January 2024, Kyowa Hakko Bio Co., Ltd. (Japan) partnered with the Agency for Science, Technology, and Research (A*STAR) to advance research on Human Milk Oligosaccharides (HMOs).
- In November 2023, Nestle Health Science (U.S.) launched a milk solution containing HMOs (Human Milk Oligosaccharides) for early-life nutrition in mainland China under the Wyeth Illume brand.
- In July 2023, DSM-Firmenich AG (Switzerland) expanded its presence in the human milk oligosaccharide (HMO) portfolio in China by submitting two new ingredients to the China National Center for Food Safety Risk Assessment (CFSA) and National Health Committee (NHC).
- In February 2023, DSM-Firmenich AG (Switzerland) received approval for its HMO ingredient – GlyCare 3FL, for applications in food and dietary supplements in the US and Australia.
Human Milk Oligosaccharides (HMOs) Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
220 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2024 |
|
CAGR |
21.2% |
|
Market Size |
USD 1.71 Billion by 2031 |
|
Segments Covered |
By Type
By Concentration
By Application
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, Netherlands, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), and the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa) |
|
Key Companies |
Chr. Hansen A/S (A part of Novonesis) (Denmark), DSM-Firmenich AG (Switzerland), Kyowa Hakko Europe GmbH (Germany), Royal FrieslandCampina N.V. (Netherlands), ZuChem Inc. (U.S.), ELICITYL S.A. (France), Dextra Laboratories Limited (U.K.), Glycosyn LLC (U.S.), Nestle Health Science (U.S.), Biosynth Ltd (U.K.), Inbiose NV (Belgium), BASF SE (Germany), and Abbott Laboratories (U.S.) |
Key questions answered in the human milk oligosaccharides (HMOs) market report:
The global human milk oligosaccharides (HMOs) market size was valued at $0.35 billion in 2023.
The market is projected to grow from $0.45 billion in 2024 to $1.71 billion by 2031.
The Human Milk Oligosaccharides (HMOs) market analysis indicates significant growth, reaching $1.71 billion by 2031 at a compound annual growth rate (CAGR) of 21.2% from 2024 to 2031.
The key companies operating in this market include Chr. Hansen A/S (A part of Novonesis) (Denmark), DSM-Firmenich AG (Switzerland), Kyowa Hakko Europe GmbH (Germany), Royal FrieslandCampina N.V. (Netherlands), ZuChem Inc. (U.S.), ELICITYL S.A. (France), Dextra Laboratories Limited (U.K.), Glycosyn LLC (U.S.), Nestle Health Science (U.S.), Biosynth Ltd (U.K.), Inbiose NV (Belgium), BASF SE (Germany), and Abbott Laboratories (U.S.), among others.
A prominent market trend in human milk oligosaccharides (HMOs) is the rising adoption of clean-label products.
By type, the 2’FL segment is forecasted to hold the largest market share.
By Concentration, the neutral segment is expected to dominate the market.
By application, the infant formula segment is poised to record the dominant position in the market.
By region, North America will hold the largest human milk oligosaccharides (HMOs) market share in 2024. However, the Asia-Pacific region is expected to witness the fastest growth, driven by growing preferences for baby nutrition, an increase in the region's newborn population, rising spending on health-related items, and expanded product offerings by several important players.
The primary drivers of human milk oligosaccharides (HMOs) market growth include the rising demand for infant nutrition, rising demand for dietary supplements, increasing awareness regarding the benefits of HMO, and increase in product innovation by various human milk oligosaccharides (HMOs) manufacturers.
The global human milk oligosaccharides (HMOs) market size was valued at $0.35 billion in 2023.
The market is projected to grow from $0.45 billion in 2024 to $1.71 billion by 2031.
The Human Milk Oligosaccharides (HMOs) market analysis indicates significant growth, reaching $1.71 billion by 2031 at a compound annual growth rate (CAGR) of 21.2% from 2024 to 2031.
The key companies operating in this market include Chr. Hansen A/S (A part of Novonesis) (Denmark), DSM-Firmenich AG (Switzerland), Kyowa Hakko Europe GmbH (Germany), Royal FrieslandCampina N.V. (Netherlands), ZuChem Inc. (U.S.), ELICITYL S.A. (France), Dextra Laboratories Limited (U.K.), Glycosyn LLC (U.S.), Nestle Health Science (U.S.), Biosynth Ltd (U.K.), Inbiose NV (Belgium), BASF SE (Germany), and Abbott Laboratories (U.S.), among others.
A prominent market trend in human milk oligosaccharides (HMOs) is the rising adoption of clean-label products.
By type, the 2’FL segment is forecasted to hold the largest market share.
By Concentration, the neutral segment is expected to dominate the market.
By application, the infant formula segment is poised to record the dominant position in the market.
By region, North America will hold the largest human milk oligosaccharides (HMOs) market share in 2024. However, the Asia-Pacific region is expected to witness the fastest growth, driven by growing preferences for baby nutrition, an increase in the region's newborn population, rising spending on health-related items, and expanded product offerings by several important players.
The primary drivers of human milk oligosaccharides (HMOs) market growth include the rising demand for infant nutrition, rising demand for dietary supplements, increasing awareness regarding the benefits of HMO, and increase in product innovation by various human milk oligosaccharides (HMOs) manufacturers.
1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation Process
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
3.1. Overview
3.2. Segmental Analysis
3.2.1. Human Milk Oligosaccharides (HMOs) Market Analysis, by Type
3.2.2. Human Milk Oligosaccharides (HMOs) Market Analysis, by Concentration
3.2.3. Human Milk Oligosaccharides (HMOs) Market Analysis, by Application
3.3. Regional Analysis
3.4. Key Players & Competitive Scenario
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Rising Demand for Infant Nutrition Supports the Growth of the Market
4.2.2. Rising Demand for Dietary Supplements Driving the Demand for Human Milk Oligosaccharides (HMOs) Market
4.2.3. Increasing Awareness Regarding the Benefits of HMO Boosting the Adoption of Human Milk Oligosaccharides (HMOs)
4.2.4. Increase in Product Innovation by Various Human Milk Oligosaccharides (HMOs) Manufacturers Supports the Market Growth
4.2.5. High Cost of Products Restraining the Market Growth
4.2.6. High Substitutions Available with Other Oligosaccharides in the Market Restrain the Market Growth
4.2.7. Increasing Technological Advancements Generating Market Growth Opportunities
4.2.8. Increasing Government Approvals for the Use of HMOs for Human Consumption Creates Opportunity for Human Milk Oligosaccharides (HMOs) Market
4.2.9. Complex Production Process Challenges the Market Growth
4.2.10. Stringent Regulatory Requirements and Approval Processes Creates Challenge for Human Milk Oligosaccharides (HMOs) Market
4.2.11. Rising Adoption of Clean Label Products
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of Substitutes
4.3.4. Threat of New Entrants
4.3.5. Degree of Competition
5. Human Milk Oligosaccharides (HMOs) Market Assessment—by Type
5.1. Overview
5.2. 2’FL
5.3. 3’FL
5.4. 3’SL
5.5. 6’SL
5.6. LNT
5.7. LNnT
5.8. DFL
6. Human Milk Oligosaccharides (HMOs) Market Assessment—by Concentration
6.1. Overview
6.2. Neutral
6.3. Acidic
7. Human Milk Oligosaccharides (HMOs) Market Assessment—by Application
7.1. Overview
7.2. Infant Formula
7.3. Dietary Supplements
7.4. Food & Beverages
7.5. Other Applications
8. Human Milk Oligosaccharides (HMOs) Market Assessment–by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Spain
8.3.5. Italy
8.3.6. Netherlands
8.3.7. Rest of Europe (RoE)
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Indonesia
8.4.7. Malaysia
8.4.8. Rest of Asia-Pacific (RoAPAC)
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Argentina
8.5.4. Rest of Latin America (RoLATAM)
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. UAE
8.6.3. South Africa
8.6.4. Rest of Middle East & Africa (RoMEA)
9. Competitive Landscape
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Contemporary Stalwarts
9.5. Market Share/Ranking Analysis, by the Key Players, 2023
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
10.1. Chr. Hansen A/S (A part of Novonesis)
10.2. DSM-Firmenich AG
10.3. Kyowa Hakko Europe GmbH
10.4. Royal FrieslandCampina N.V.
10.5. ZuChem Inc.
10.6. ELICITYL S.A.
10.7. Dextra Laboratories Limited
10.8. Glycosyn LLC
10.9. Nestle Health Science
10.10. Biosynth Ltd
10.11. Inbiose NV
10.12. BASF SE
10.13. Abbott Laboratories
10.14. Other Companies
(Note: SWOT Analysis will be provided for the Top 5 Companies)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1. Global Human Milk Oligosaccharides (HMOs) Market, by Type, 2022-2031 (USD Million)
Table 2. Global 2’FL Market, by Country/Region, 2022-2031 (USD Million)
Table 3. Global 3’FL Market, by Country/Region, 2022-2031 (USD Million)
Table 4. Global 3’SL Market, by Country/Region, 2022-2031 (USD Million)
Table 5. Global 6’SL Market, by Country/Region, 2022-2031 (USD Million)
Table 6. Global LNT Market, by Country/Region, 2022-2031 (USD Million)
Table 7. Global LNnT Market, by Country/Region, 2022-2031 (USD Million)
Table 8. Global DFL Market, by Country/Region, 2022-2031 (USD Million)
Table 9. Global Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022-2031 (USD Million)
Table 10. Global Neutral Human Milk Oligosaccharides (HMOs) Market, by Country/Region, 2022-2031 (USD Million)
Table 11. Global Acidic Human Milk Oligosaccharides (HMOs) Market, by Country/Region, 2022-2031 (USD Million)
Table 12. Global Human Milk Oligosaccharides (HMOs) Market, by Application, 2022-2031 (USD Million)
Table 13. Global Human Milk Oligosaccharides (HMOs) Market for Infant Formula, by Country/Region, 2022-2031 (USD Million)
Table 14. Global Human Milk Oligosaccharides (HMOs) Market for Dietary Supplements, by Country/Region, 2022-2031 (USD Million)
Table 15. Global Human Milk Oligosaccharides (HMOs) Market for Food & Beverages, by Country/Region, 2022-2031 (USD Million)
Table 16. Global Human Milk Oligosaccharides (HMOs) Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
Table 17. Human Milk Oligosaccharides (HMOs) Market, by Region, 2022-2031 (USD Million)
Table 18. North America: Human Milk Oligosaccharides (HMOs) Market, by Country, 2022-2031 (USD Million)
Table 19. North America: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 20. North America: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 21. North America: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 22. U.S.: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 23. U.S.: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 24. U.S.: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 25. Canada: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 26. Canada: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 27. Canada: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 28. Europe: Human Milk Oligosaccharides (HMOs) Market, by Country/Region, 2022-2031 (USD Million)
Table 29. Europe: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 30. Europe: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 31. Europe: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 32. Germany: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 33. Germany: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 34. Germany: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 35. France: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 36. France: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 37. France: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 38. U.K.: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 39. U.K.: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 40. U.K.: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 41. Spain: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 42. Spain: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 43. Spain: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 44. Italy: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 45. Italy: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 46. Italy: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 47. Netherlands: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 48. Netherlands: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 49. Netherlands: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 50. Rest of Europe: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 51. Rest of Europe: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 52. Rest of Europe: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 53. Asia-Pacific: Human Milk Oligosaccharides (HMOs) Market, by Country/Region, 2022-2031 (USD Million)
Table 54. Asia-Pacific: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 55. Asia-Pacific: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 56. Asia-Pacific: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 57. China: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 58. China: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 59. China: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 60. Japan: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 61. Japan: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 62. Japan: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 63. India: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 64. India: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 65. India: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 66. Australia: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 67. Australia: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 68. Australia: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 69. South Korea: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 70. South Korea: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 71. South Korea: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 72. Indonesia: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 73. Indonesia: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 74. Indonesia: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 75. Malaysia: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 76. Malaysia: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 77. Malaysia: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 78. Rest of Asia-Pacific: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 79. Rest of Asia-Pacific: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 80. Rest of Asia-Pacific: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 81. Latin America: Human Milk Oligosaccharides (HMOs) Market, by Country/Region, 2022-2031 (USD Million)
Table 82. Latin America: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 83. Latin America: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 84. Latin America: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 85. Brazil: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 86. Brazil: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 87. Brazil: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 88. Argentina: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 89. Argentina: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 90. Argentina: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 91. Mexico: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 92. Mexico: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 93. Mexico: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 94. Rest of Latin America: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 95. Rest of Latin America: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 96. Rest of Latin America: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 97. Middle East & Africa: Human Milk Oligosaccharides (HMOs) Market, by Country/Region, 2022-2031 (USD Million)
Table 98. Middle East & Africa: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 99. Middle East & Africa: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 100. Middle East & Africa: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 101. Saudi Arabia: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 102. Saudi Arabia: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 103. Saudi Arabia: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 104. UAE: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 105. UAE: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 106. UAE: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 107. South Africa: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 108. South Africa: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 109. South Africa: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 110. Rest of Middle East & Africa: Human Milk Oligosaccharides (HMOs) Market, by Type, 2022–2031 (USD Million)
Table 111. Rest of Middle East & Africa: Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2022–2031 (USD Million)
Table 112. Rest of Middle East & Africa: Human Milk Oligosaccharides (HMOs) Market, by Application, 2022–2031 (USD Million)
Table 113. Recent Developments, by Company (2020–2024)
List of Figures
Figure 1. Research Process
Figure 2. Secondary Sources Referenced for this Study
Figure 3. Primary Research Techniques
Figure 4. Key Executives Interviewed
Figure 5. Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6. Market Sizing and Growth Forecast Approach
Figure 7. In 2024, the 2’FL Segment to Dominate the Global Human Milk Oligosaccharides (HMOs) Market
Figure 8. In 2024, the Neutral Segment to Dominate the Global Human Milk Oligosaccharides (HMOs) Market
Figure 9. In 2024, the Infant Formula Segment to Dominate the Global Human Milk Oligosaccharides (HMOs) Market
Figure 10. In 2024, North America Dominates the Overall Human Milk Oligosaccharides (HMOs) Market
Figure 11. Impact Analysis of Market Dynamics
Figure 12. Human Milk Oligosaccharides (HMOs) Market: Porter’s Five Forces Analysis
Figure 13. Global Human Milk Oligosaccharides (HMOs) Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 14. Global Human Milk Oligosaccharides (HMOs) Market, by Concentration, 2024 Vs. 2031 (USD Million)
Figure 15. Global Human Milk Oligosaccharides (HMOs) Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 16. North America: Human Milk Oligosaccharides (HMOs) Market Snapshot (2024)
Figure 17. Europe: Human Milk Oligosaccharides (HMOs) Market Snapshot (2024)
Figure 18. Asia-Pacific: Human Milk Oligosaccharides (HMOs) Market Snapshot (2024)
Figure 19. Latin America: Human Milk Oligosaccharides (HMOs) Market Snapshot (2024)
Figure 20. Middle East & Africa: Human Milk Oligosaccharides (HMOs) Market Snapshot (2024)
Figure 21. Key Growth Strategies Adopted by Leading Players (2021–2024)
Figure 22. Global Human Milk Oligosaccharides (HMOs) Market Competitive Benchmarking, by Type
Figure 23. Competitive Dashboard: Global Human Milk Oligosaccharides (HMOs) Market
Figure 24. Chr. Hansen A/S (A part of Novonesis): Financial Overview (2023)
Figure 25. Royal FrieslandCampina N.V.: Financial Overview (2023)
Figure 26. Nestle Health Science: Financial Overview (2023)
Figure 27. BASF SE: Financial Overview (2024)
Figure 28. Abbott Laboratories: Financial Overview (2022)
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Almond Milk Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Oct-2024
Plant-based Milk Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Jan-2024
Human Nutrition Market - Global Opportunity Analysis and Industry Forecast (2023-2030)
Published Date: Jun-2023
Dairy Processing Equipment Market - Global Opportunity Analysis and Industry Forecast (2019-2024)
Published Date: Mar-2019
Dairy Ingredients Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Aug-2024
